Literature DB >> 14303339

STEROID CATARACTS. POSTERIOR SUBCAPSULAR CATARACT FORMATION IN RHEUMATOID ARTHRITIS PATIENTS ON LONG TERM STEROID THERAPY.

R W SPENCER, S Y ANDELMAN.   

Abstract

Entities:  

Keywords:  ADRENAL CORTEX HORMONES; ARTHRITIS, RHEUMATOID; CATARACT; DRUG THERAPY; PHARMACOLOGY; RATS; TOXICOLOGIC REPORT; TRIAMCINOLONE ACETONIDE

Mesh：

Substances：

Year:  1965        PMID： 14303339     DOI： 10.1001/archopht.1965.00970040040009

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN： 0003-9950


× No keyword cloud information.
  7 in total

1.  Episcleritis and scleritis. A study of their clinical manifestations and association with rheumatoid arthritis.

Authors:  D D McGavin; J Williamson; J V Forrester; W S Foulds; W W Buchanan; W C Dick; P Lee; R N MacSween; K Whaley
Journal:  Br J Ophthalmol       Date:  1976-03       Impact factor: 4.638

2.  Posterior subcapsular cataracts: posttransplantation in children.

Authors:  R N Fine; G Offner; W A Wilson; M R Mickey; A F Pennisi; M H Malekzadeh
Journal:  Ann Surg       Date:  1975-11       Impact factor: 12.969

Review 3.  Eye on statins: A comprehensive review.

Authors:  Evan A Olson; Dean P Hainsworth; Geetha Davis; John C Hagan
Journal:  Mo Med       Date:  2013 Jul-Aug

4.  Ocular complications in renal transplant recipients.

Authors:  C R Pavlin; G A deVeber; G T Cook; L D Chisholm
Journal:  Can Med Assoc J       Date:  1977-08-20       Impact factor: 8.262

Review 5.  Clinically important ocular reactions to systemic drug therapy.

Authors:  I G Rennie
Journal:  Drug Saf       Date:  1993-09       Impact factor: 5.606

6.  An increase in phosphorylation and truncation of crystallin with the progression of cataracts.

Authors:  Hui-Ju Lin; Chien-Chen Lai; Shiuan-Yi Huang; Wei-Yi Hsu; Fuu-Jen Tsai
Journal:  Curr Ther Res Clin Exp       Date:  2013-06

Review 7.  Etiopathogenesis of cataract: an appraisal.

Authors:  Varun B Gupta; Manjusha Rajagopala; Basavaiah Ravishankar
Journal:  Indian J Ophthalmol       Date:  2014-02       Impact factor: 1.848
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.